Skip to content

Clinical trials

Phase 1 Immune System Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Phase: Phase 1 Country / region: Germany Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20131
20173
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nordic Nanovector2
UCB Pharma2
Bioverativ, a Sanofi company1
Hutchmed1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases6
Autoimmune Diseases4
AIDS-Related Complex2
Blood Platelet Disorders2
Connective Tissue Diseases2
Hematologic Diseases2
Lupus Erythematosus, Systemic2
Lymphatic Diseases2
Lymphoma2
Lymphoma, Non-Hodgkin2

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.